China's new device registration fees hit Class III device makers hardest
This article was originally published in SRA
Companies seeking to register Class II and III medical devices for sale in China now have to start paying fees amounting to tens of thousands of US dollars to the China Food and Drug Administration1,2.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.